Related Experiment Video
Updated: Jul 24, 2025
Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
Published on: June 7, 2020
Heterogeneity in functional genetic screens: friend or foe?
David W Vredevoogd1, Daniel S Peeper1
1Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.
Abstract:
Functional genetic screens to uncover tumor-intrinsic nodes of immune resistance have uncovered numerous mechanisms by which tumors evade our immune system. However, due to technical limitations, tumor heterogeneity is imperfectly captured with many of these analyses. Here, we provide an overview of the nature and sources of heterogeneity that are relevant for tumor-immune interactions. We argue that this heterogeneity may actually contribute to the discovery of novel mechanisms of immune evasion, given a sufficiently large and heterogeneous set of input data. Taking advantage of tumor cell heterogeneity, we provide proof-of-concept analyses of mechanisms of TNF resistance. Thus, consideration of tumor heterogeneity is imperative to increase our understanding of immune resistance mechanisms.
Insights
Tumor heterogeneity, often overlooked, is key to understanding how cancers evade the immune system. Analyzing diverse tumor data can reveal new immune evasion mechanisms, like tumor necrosis factor (TNF) resistance.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Functional genetic screens identify tumor-intrinsic mechanisms of immune resistance.
- Technical limitations in current analyses imperfectly capture tumor heterogeneity.
- Tumor heterogeneity plays a critical role in tumor-immune interactions.
Purpose of the Study:
- To provide an overview of tumor heterogeneity relevant to immune evasion.
- To highlight how tumor heterogeneity can aid in discovering novel immune evasion mechanisms.
- To demonstrate proof-of-concept analyses of tumor necrosis factor (TNF) resistance using tumor cell heterogeneity.
Main Methods:
- Overview of tumor heterogeneity sources and types.
- Analysis of large, heterogeneous tumor datasets.
- Proof-of-concept studies focusing on TNF resistance mechanisms.
Main Results:
- Tumor heterogeneity is a significant factor in immune evasion.
- Heterogeneous data enables the discovery of new immune evasion strategies.
- Specific mechanisms of TNF resistance were identified through heterogeneous analyses.
Conclusions:
- Considering tumor heterogeneity is essential for advancing the understanding of cancer immune resistance.
- Leveraging tumor cell heterogeneity can uncover novel therapeutic targets.
- Future research should incorporate diverse tumor data to fully elucidate immune evasion pathways.
